Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ORGO · against 90 other Healthcare companies of similar size
Ranked #59 of 91 · scores higher than 33% of peers
Bars: peers in each 10-point band of the growth score12 peers with a growth score of 30–39, including ORGO · Click a bar to see the companies
Mainly because of its earnings per share growth and 3-year revenue growth, which are weaker than most Healthcare peers.
| Metric | ORGO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 97 reported | 6.5% | 5.2% | 56% | 33% | |
| Earnings per share growthHigher is better · 29 reported | Not reported | 5.0% | — | — | 33% |
| 3-year revenue growthHigher is better · 89 reported | 0.0% | 2.9% | 40% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 592M ILS (≈$160M) | 99 | 84 | |
| 1 | 90M USD | 99 | 27 | |
| 1 | 649M SEK (≈$65M) | 99 | 29 | |
| 1 | 97M USD | 99 | 63 | |
| 5 | 5.7B TWD (≈$177M) | 98 | 65 | |
| 55 | 376M BRL (≈$68M) | 32 | 56 | |
| 58 | 1.4B SEK (≈$143M) | 31 | 47 | |
| 59 | 122.4B KRW (≈$88M) | 30 | 34 | |
| 59 | 834M HKD (≈$107M) | 30 | 57 | |
| 59 | 107M USD | 30 | 26 | |
| 62 | 1.6B HKD (≈$209M) | 29 | 54 | |
| 62 | 60M USD | 29 | 33 | |
| 64 | 1.4B HKD (≈$180M) | 26 | 61 | |
| 65 | 172.4B KRW (≈$124M) | 24 | 26 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score